Hepatitis

facebooktwitterlinkedinmail

Research on Hepatitis with Livotone For Ayush Herbals at Dayanand Ayurvedic College & Hospital

Material and Methods

25 patients were selected from OPD/IPD of Dayanand Ayurvedic Hospital

Symptoms taken

  • Anorexia
  • Pruritis
  • Hepatomegaly
  • Fever
  • Malaise
  • Nausea
  • Severe weakness
  • Yellowish urine
  • Yellowish eyes

Liver function tests selected

  • Serum bilirubin
  • Total
  • Direct
  • Indirect
  • Serum alkaline phosphatase
  • SGOT (IU)
  • SGPT (IU)

Formulation of ‘Livotone’

  • Silybum marianum
  • Picrorhiza kurroa
  • Borhavia diffusa
  • Phyllanthus amarus
  • Swertia chirayita
  • Eclipta alba
  • Tephrosia purpurea
  • Andrographis paniculata

Exclusion criteria

  • Patients having cardiac, renal, endocrine disorders
  • Patients having inconclusive diagnosis
  • Patients of age <20 & >70 years

Inclusion criteria

  • Patients of age group between 30 – 70 years
  • Duration of disease 0 – 3 years
  • Selection of patients
  1. 25 patients were selected from OPD/IPD of Dayanand Ayurvedic hospital
  2. Trial period was for 3 months duration
  3. Patient were instructed to take livotone regularly

 

Other Recommendations
1. Few yoga postures
2. Sheetali pranayama
3. Ujjayi breathing
4. Meditation for 20 minutes
5. Morning/Evening walk for 30-45 minutes

Results

  • After completing trial of three months every patient was again subjected to same laboratory testing as before starting livotone to find out the positive changes.
  • Liver function tests were parameters for assessment

Incidence of Prakriti (Constitution)

T Calculation of Investigations Before & After Treatment
Incidence of Prakriti Livotone

 

 

 

 

 


Liver Funtion Test Livotone

T Calculation of Investigations Before & After Treatment

LIVER

FUNCTION

TEST

Before

Treatment

(Mean +SD)

After

Treatment

(Mean +SD)

Difference

(Mean +S.D.)

Tcal

TTab

Serum Bilirubin

(Mg/dl)

Total

6.90+34.54

2.47+12.37

4.43+1.96

11.3

TTab <0.01

Direct

4.63+23.18

0.188+0.94

4.45+1.24

17.94

TTab <0.01

Indirect

2.18+10.92

0.448+2.24

1.73+0.76

11.38

TTab <0.01

Serum alkaline

phosphatase

IU / dl

100.4+502

51.44+257.2

50.08+15.95

15.7

TTab <0.01

SGOT (IU)

126+630

45.6+228

80.4+5.26

76.43

TTab <0.01

SGPT (IU)

710+3550

45.8+229

664.2+166.58

19.94

TTab <0.01

Symptoms Before Treatment and After Treatment

SYMPTOMS

BEFORE

TREATMENT

AFTER

TREATMENT

ANOREXIA

24  (96%)

10 (40%)

PRURITIS

23 (92%)

7 (28%)

HEPATOMEGALY

23 (92%)

10 (40%)

FEVER

24 (96%)

6 (24%)

MALAISE

15 (60%)

5 (20%)

NAUSEA

20 (80%)

5 (20%)

SEVERE WEAKNESS

07 (28%)

2 (8%)

YELLOWISH URINE

23 (92%)

7 (28%)

YELLOWISH EYES

20 (80%)

4 (16%)